Bristol-Myers Squibb Company
Bristol Myers Squibb
BMY · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $48.2B
- Assets
- $90B
- SEC filing
- DEF 14A
- Filed
- March 25, 2026
Executive Compensation
Compensation reported for Bristol Myers Squibb’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Christopher S. Boerner
Ph.d.board Chair And Chief Executive Officer
$21.9M
Reported total
- Salary
- $1,586,346
- Stock awards
- $16,061,399
- Incentives
- $3,754,684
- Option awards
- $0
- Other
- $477,490
Samit Hirawat
, M.D. Former EVP, Chief Medical Officer, Head of Development
$10.3M
Reported total
- Salary
- $964,904
- Stock awards
- $5,815,320
- Incentives
- $928,658
- Option awards
- $0
- Other
- $2,625,351
Cristian Massacesi
, M.D. EVP, Chief Medical Officer, Head of Development
$10.1M
Reported total
- Salary
- $388,462
- Stock awards
- $7,853,994
- Incentives
- $1,785,876
- Option awards
- $0
- Other
- $44,618
Adam Lenkowsky
Evp, Chief Commercialization Officer
$9.3M
Reported total
- Salary
- $1,131,731
- Stock awards
- $6,136,800
- Incentives
- $1,794,732
- Option awards
- $0
- Other
- $277,089
David V. Elkins
EVP and Chief Financial Officer
$9.2M
Reported total
- Salary
- $1,140,442
- Stock awards
- $5,981,513
- Incentives
- $1,799,484
- Option awards
- $0
- Other
- $256,151
Greg Meyers
EVP, Chief Digital and Technology Officer
$7.2M
Reported total
- Salary
- $1,072,692
- Stock awards
- $4,209,168
- Incentives
- $1,669,036
- Option awards
- $0
- Other
- $230,277
Christopher S. Boerner
Ph.d.board Chair And Chief Executive Officer
$21.9M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 25, 2026.
- Salary
- $1.6M
- Stock Awards
- $16.1M
- Incentives
- $3.8M
- Other
- $477K
Historical Compensation
Christopher S. Boerner total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,586,346 | $16,061,399 | $21,879,919 |
| 2024 | $1,536,538 | $13,643,063 | $18,787,618 |
| 2023 | $1,256,921 | $5,326,178 | $8,461,833 |
Named Executive Officers
Christopher S. Boerner
Ph.d.board Chair And Chief Executive Officer
Bristol Myers Squibb · BMY
$21.9M
FY 2025 · DEF 14A
David V. Elkins
EVP and Chief Financial Officer
Bristol Myers Squibb · BMY
$9.2M
FY 2025 · DEF 14A
Cristian Massacesi
, M.D. EVP, Chief Medical Officer, Head of Development
Bristol Myers Squibb · BMY
$10.1M
FY 2025 · DEF 14A
Adam Lenkowsky
Evp, Chief Commercialization Officer
Bristol Myers Squibb · BMY
$9.3M
FY 2025 · DEF 14A
Greg Meyers
EVP, Chief Digital and Technology Officer
Bristol Myers Squibb · BMY
$7.2M
FY 2025 · DEF 14A
Samit Hirawat
, M.D. Former EVP, Chief Medical Officer, Head of Development
Bristol Myers Squibb · BMY
$10.3M
FY 2025 · DEF 14A
Source information
- Company
- Bristol-Myers Squibb Company
- Ticker
- BMY · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 25, 2026
- SEC accession number
- 0000014272-26-000006
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →